PMID- 19506118 OWN - NLM STAT- MEDLINE DCOM- 20090820 LR - 20221102 IS - 1538-3687 (Electronic) IS - 0003-9942 (Print) IS - 0003-9942 (Linking) VI - 66 IP - 8 DP - 2009 Aug TI - Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. PG - 958-63 LID - 10.1001/archneurol.2009.132 [doi] AB - OBJECTIVE: To determine if exclusive breastfeeding protects against postpartum relapses of multiple sclerosis (MS) and, if so, whether this protection is related to prolonged lactational amenorrhea. DESIGN: We conducted structured interviews to assess clinical, menstrual, and breastfeeding history during each trimester and 2, 4, 6, 9, and 12 months postpartum and collected neurological examination findings from the treating physicians of women with MS. Hazards ratios (HRs) were adjusted for measures of disease severity and age. SETTING: Kaiser Permanente Northern California and Stanford University. PARTICIPANTS: We prospectively enrolled 32 pregnant women with MS and 29 age-matched, pregnant controls. Main Outcome Measure Postpartum relapse. RESULTS: Of the 52% of women with MS who did not breastfeed or began regular supplemental feedings within 2 months postpartum, 87% had a postpartum relapse, compared with 36% of the women with MS who breastfed exclusively for at least 2 months postpartum (unadjusted HR, 5.0; 95% confidence interval, 1.7-14.2; P = .003; adjusted HR, 7.1; 95% confidence interval, 2.1-24.3; P = .002). Sixty percent reported that the primary reason for foregoing exclusive breastfeeding was to resume MS therapies. Women who breastfed exclusively had a later return of menses (P = .001) than women who did not, and lactational amenorrhea was associated with a reduced risk of postpartum relapses (P = .01). CONCLUSIONS: Our findings suggest that exclusive breastfeeding and concomitant suppression of menses significantly reduce the risk of postpartum relapses in MS. Our findings call into question the benefit of foregoing breastfeeding to start MS therapies and should be confirmed in a larger study. FAU - Langer-Gould, Annette AU - Langer-Gould A AD - Stanford University School of Medicine, HRP Redwood Bldg, Room T202 MC 5405, Stanford, CA 94305, USA. annette1@stanford.edu FAU - Huang, Stella M AU - Huang SM FAU - Gupta, Rohit AU - Gupta R FAU - Leimpeter, Amethyst D AU - Leimpeter AD FAU - Greenwood, Eleni AU - Greenwood E FAU - Albers, Kathleen B AU - Albers KB FAU - Van Den Eeden, Stephen K AU - Van Den Eeden SK FAU - Nelson, Lorene M AU - Nelson LM LA - eng GR - K23 NS043207/NS/NINDS NIH HHS/United States GR - K23NS/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20090608 PL - United States TA - Arch Neurol JT - Archives of neurology JID - 0372436 SB - IM CIN - Arch Neurol. 2009 Dec;66(12):1580-1; author reply 1581. PMID: 20008670 CIN - Arch Neurol. 2009 Dec;66(12):1580; author reply 1581. PMID: 20008671 MH - Breast Feeding/*adverse effects MH - Cohort Studies MH - Disability Evaluation MH - Female MH - Follow-Up Studies MH - Humans MH - Infant, Newborn MH - Kaplan-Meier Estimate MH - Multiple Sclerosis/diagnosis/*etiology MH - Pregnancy MH - Pregnancy Complications/diagnosis MH - Prospective Studies MH - Puerperal Disorders/*etiology MH - Recurrence MH - Risk PMC - PMC9622216 MID - NIHMS1037685 EDAT- 2009/06/10 09:00 MHDA- 2009/08/21 09:00 PMCR- 2022/10/31 CRDT- 2009/06/10 09:00 PHST- 2009/06/10 09:00 [entrez] PHST- 2009/06/10 09:00 [pubmed] PHST- 2009/08/21 09:00 [medline] PHST- 2022/10/31 00:00 [pmc-release] AID - 2009.132 [pii] AID - 10.1001/archneurol.2009.132 [doi] PST - ppublish SO - Arch Neurol. 2009 Aug;66(8):958-63. doi: 10.1001/archneurol.2009.132. Epub 2009 Jun 8.